8 Pharmacovigilance Providers for Clinical Trials in 2026

A pharmacovigilance provider handles the ongoing work of detecting, assessing, and reporting adverse events tied to an investigational or marketed drug, a legal obligation that runs from a compound's first clinical trial through its entire time on the market. This kind of pharmacovigilance provider ranges from software platforms that manage a company's global safety database, to consultancies that supply a Qualified Person for Pharmacovigilance (QPPV) and run day-to-day case processing, to specialized tools that automate the literature monitoring regulators require but most safety teams struggle to keep up with manually.

The pharmacovigilance providers below are listed in no particular order. Between them, these companies and providers cover multivigilance safety database software, QPPV and case processing consultancies, AI-driven literature monitoring, and full-service drug safety CROs supporting both clinical and post-marketing obligations.

AB-Cube

AB-Cube launched the industry's first cloud-based pharmacovigilance software in 2006, and the company's flagship SafetyEasy Suite has since grown into a multivigilance platform covering pharmacovigilance, medical device vigilance, cosmetovigilance, and nutrivigilance within a single unified database. Founded by CEO Matthieu Doresse, the Paris-based company achieved a major milestone in 2021 when France's national medicines agency, ANSM, deployed SafetyEasy Suite as its new pharmacovigilance database, migrating 1 million cases within a single day from its previous provider. AB-Cube also built IntakEasy, an automated intake tool, and iTAP Triage, a companion environment for signal detection, both designed to plug directly into the SafetyEasy Suite workflow. In 2023, the company's software passed ICH E2B(R3) testing for China's ICSR reporting requirements, extending its localized compliance coverage into the Chinese market.

Arriello

Arriello has provided pharmacovigilance, regulatory affairs, and quality and compliance consultancy to the pharmaceutical and biotech sectors since founder Alan established the company in 2008, building it into a team of more than 130 employees operating across 143 countries through a network of 128 global vendor partners. Headquartered in Dublin, Ireland, with additional offices in the US, Portugal, and the Czech Republic, the company recently scaled affiliate pharmacovigilance support across more than 25 countries for a client, migrating 1,200 safety cases while establishing inspection-ready local operations. Arriello was named Pharma Contract Services Company of the Year at the Pharma Industry Awards and holds ISO 27001 certification for data security alongside ISO 9001 quality certification. The company's services span the full product lifecycle, from clinical safety through post-submission regulatory affairs and ongoing pharmacovigilance obligations.

Awinsa Life Sciences

Awinsa Life Sciences was founded by Dr. Sanjeev Miglani, who brings more than 24 years of experience in medicine, pharmacovigilance, and clinical research after roles at Ranbaxy and CliniRx, alongside co-founder Dr. Mugdha Chopra, a dental surgeon with more than 20 years of pharmacovigilance database and systems experience. The company, based in Princeton, New Jersey, provides end-to-end pharmacovigilance services spanning case processing, signal management, aggregate reports, risk management plans, and QPPV oversight for both clinical trial and post-marketing safety obligations. Awinsa has published case studies detailing its work supporting biosimilar development programs, positioning itself as a strategic pharmacovigilance partner for that specific segment of the industry. The company's global operations span North America, Europe, and Asia, and its leadership team has presented at industry events including DIA Europe.

biologit

biologit built its MLM-AI platform to automate scientific literature monitoring, the mandatory pharmacovigilance activity of screening published medical literature for adverse events and safety signals, using AI models the company says can produce productivity gains of up to 70 percent over manual review. Co-founded by CEO Nicole Baker, whose technology was first incubated at Trinity College Dublin before evolving into biologit through Enterprise Ireland's New Frontiers program, the Dublin-based company raised a €2 million funding round led by Enterprise Ireland to scale its team. In April 2025, biologit launched what it describes as a world-first automated solution for local literature monitoring, a resource-intensive pharmacovigilance requirement that involves searching non-indexed regional publications for safety signals, already live at a top-10 pharmaceutical company. The company's platform covers literature screening for human and veterinary pharmacovigilance as well as medical device, cosmetic, and nutraceutical safety monitoring.

Biomapas

Biomapas has operated as a full-service CRO from its base in Kaunas, Lithuania since 2001, building a pan-European pharmaceutical services business spanning clinical research, regulatory affairs, pharmacovigilance, and medical information across Europe, the CIS/EAEU region, and MENA. The company's pharmacovigilance team uses Vault Safety to manage individual case safety reports and provide real-time oversight of adverse events for clients that range from large pharmaceutical companies to smaller biotechs unable to justify building an in-house safety system. Biomapas made its first global growth move by joining forces with Delta PV, a specialist in local literature monitoring credited with setting up screening projects across more than 120 countries in as little as two weeks. In February 2026, Biomapas appointed Xavier Duburcq as its new Chief Executive Officer, continuing the company's expansion beyond its original Baltic base.

Intuvigilance

Intuvigilance operates from offices in the UK and Cyprus, offering global QPPV and Local QPPV services, scientific literature monitoring, and pharmacovigilance system oversight to clients ranging from large pharmaceutical companies to small and medium-sized biotechs. The company positions its strategic partnerships with health authorities and market leaders as its differentiator, particularly for helping build pharmacovigilance foundations in emerging markets and healthcare organizations that lack established safety infrastructure. Intuvigilance holds ISO certifications spanning quality management (9001), environmental management (14001), occupational health and safety (18001), and information security (27001), and runs a centralized weekly literature screening service through its team of QPPVs. The company's regulatory reach spans North America, Latin America, Asia Pacific, Europe, the Middle East, Africa, Russia, and the CIS countries.

PharSafer

PharSafer Associates was founded in 2003 by Dr. Graeme Ladds, who spent the prior 11 years running his own pharmacovigilance consultancy after starting his career at Ashbourne Pharmaceuticals as Head of Drug Safety and Medical Information in 1989. Based in Guildford, England, the company operates as a specialist CRO in global clinical and post-marketing drug safety, offering pharmacovigilance, signal detection, medical affairs, auditing, and regulatory strategy services, and runs a dedicated training arm called SaPhar as a sister company. PharSafer's services extend beyond human pharmaceuticals into cosmetovigilance and veterinary pharmacovigilance, and the company positions itself as able to operate as a client's complete outsourced pharmacovigilance and medical department. Ladds has more than three decades of pharmaceutical industry experience, including prior roles building pharmacovigilance systems and leading regulatory inspection preparation across Europe and the US.

Primevigilance

PrimeVigilance was established in 2008 by former pharmacovigilance regulators and has since grown into a subsidiary of Ergomed plc, a UK-based CRO that acquired the company at its 2014 IPO. The company runs its case processing and signal detection work on ARISg, a proprietary global drug safety database that supports rapid data assessment for aggregate report production and statutory electronic case reporting to regulatory authorities. PrimeVigilance has expanded through acquisition, including UK medical information provider Sound Opinion in 2015 and Ashfield Pharmacovigilance, a US-based safety services provider it acquired from UDG Healthcare for $10 million in 2020. Operating from hubs across Europe, the US, and Japan, the company delivers end-to-end clinical safety, post-marketing pharmacovigilance, and medical information services alongside sister companies Ergomed CRO and ADAMAS Consulting within the broader Ergomed Group.

Explore the full Pharmacovigilance landscape

The companies above represent a portion of a much larger field.

Diligent's platform includes over 355 Pharmacovigilance Vendors, with Vendor qualification data available on demand. Book a demo to see the vendors and qualification reports available on the platform.

This article is intended as an informational overview of vendors operating in this space. Inclusion on this list does not constitute an endorsement, recommendation, or qualification by Diligent.